GLUEMonte Rosa Therapeutics, Inc.Mar 20, 2025Q4 2024
Read transcript →Monte Rosa Therapeutics, Inc. (GLUE) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$10.66
+1.62%
Mkt Cap $909.44M
GLUEMonte Rosa Therapeutics, Inc.Mar 20, 2025GLUEMonte Rosa Therapeutics, Inc.Mar 20, 2025